Home
JournalsCollections
For Authors For Reviewers For Editorial Board Members
Article Processing Charges Open Access
Ethics Advertising Policy
Editorial Policy Resource Center
Company Information Contact Us Membership Collaborators Partners
OPEN ACCESS

Research progress in the imaging diagnosis of non-alcoholic fatty pancreas disease

  • Zhao-Chun Chi1,*
Gastroenterology & Hepatology Research   2021;3(1):4

doi: 10.53388/ghr2021-03-030

Published online:

 Author information

Citation: Chi ZC. Research progress in the imaging diagnosis of non-alcoholic fatty pancreas disease. Gastroenterol & Hepatol Res. 2021;3(1):4. doi: 10.53388/ghr2021-03-030.

Abstract

Currently, imaging modalities such as ultrasonography, magnetic resonance imaging (MRI), and computed tomography (CT) are considered the method of choice for diagnosing non-alcoholic fatty pancreas disease. In addition, imaging-based clinical examination methods such as B-scan ultrasonography, transient elastography, and MRI-proton density fat fraction are the most widely used and have a high diagnostic value. Endoscopic ultrasonography is more accurate than CT and MRI in diagnosing pancreatic steatosis. MRI is a sensitive, non-invasive, and safe inspection method and also the best imaging technique to assess pancreatic steatosis. However, no clear consensus has been reached on diagnostic methodology for pancreatic fat.

Keywords

non-alcoholic fatty pancreatic disease, imaging diagnosis

About this Article

Cite this article
Chi ZC. Research progress in the imaging diagnosis of non-alcoholic fatty pancreas disease. Gastroenterol & Hepatol Res. 2021;3(1):4. doi: 10.53388/ghr2021-03-030.
Copy Export to RIS Export to EndNote
Article History
Received Revised Accepted Published
March 12, 2021
DOI http://dx.doi.org/10.53388/ghr2021-03-030